»

DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2008 archives
Click here to return to the current data set

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Generic Name: hydrocortisone sodium succinate

Summary for Generic Name: hydrocortisone sodium succinate

Tradenames:3
Patents:0
Applicants:7
NDAs:25
Drug Master File Entries: see list48
Suppliers: see list2
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents

Pharmacology for Ingredient: hydrocortisone sodium succinate

Clinical Trials for: hydrocortisone sodium succinate

Contribution of Salivary Cortisol in the Detection of Infra-clinic Cortisol Adenoma (ACIC)
Status: Recruiting Condition: Obesity

Hydrocortisone for BPD
Status: Recruiting Condition: Infant, Newborn; Infant, Small for Gestational Age; Infant, Very Low Birth Weight; Infant, Premature; Bronchopulmonary Dysplasia

Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
Status: Recruiting Condition: Major Depressive Disorder; Anxiety Disorders

Adherence to Topical Hydrocortisone 17-Butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis
Status: Active, not recruiting Condition: Atopic Dermatitis

Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency
Status: Completed Condition: Primary Adrenal Insufficiency

Once-Daily Oral Modified-Release Hydrocortisone in Patients With Adrenal Insufficiency
Status: Completed Condition: Adrenal Insufficiency

Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)
Status: Completed Condition: Adrenal Insufficiency

Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
Status: Withdrawn Condition: Sepsis; Adrenal Insufficiency

Glucocorticoid Treatment in Addison's Disease
Status: Completed Condition: Addison's Disease

Continuous Subcutaneous Hydrocortisone Infusion In Addison`s Disease and Type 1 Diabetes
Status: Not yet recruiting Condition: Addison Disease; Type 1 Diabetes

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Abbott
A-HYDROCORT
hydrocortisone sodium succinate
INJECTABLE; INJECTION085928Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Abbott
A-HYDROCORT
hydrocortisone sodium succinate
INJECTABLE; INJECTION089577Apr 11, 1989DISCNNo<disabled><disabled>
Abbott
A-HYDROCORT
hydrocortisone sodium succinate
INJECTABLE; INJECTION089578Apr 11, 1989DISCNNo<disabled><disabled>
Abbott
A-HYDROCORT
hydrocortisone sodium succinate
INJECTABLE; INJECTION089579Apr 11, 1989DISCNNo<disabled><disabled>
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

No commitment, no credit card required
First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639


`abc